Michael Sextro
15 works · 2,515 citations · h-index 11
Top works
- Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial
- Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease
- BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
- Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.
- European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
- Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
- Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels
- Safety of AlloPBPCT donors: biometrical considerations on monitoring long term risks.
- BEACOPP: A new regimen for advanced Hodgkin’s disease
- Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF
- Lymphocyte predominant Hodgkin's disease — a workshop report
- How to restrict liver biopsy to high-risk patients in early-stage Hodgkin's disease
- W4247397165
- Lymphocyte-rich classical Hodgkin's disease (LRCHD): Clinical relevance of a provisional entity